Skip to main content
. 2014 Jul 28;6(6):567–572. doi: 10.4168/aair.2014.6.6.567

Fig. 5.

Fig. 5

The effect of H1R antagonist fexofenadine on the phosphorylation of mitogen-activated protein kinases (ERK, p38, JNK) was evaluated by Western blotting (representative of independent experiments).

U0126, ERK inhibitor; SB203580, p38 inhibitor; SP600125, JNK inhibitor.